StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)

Close on Nov 18, 2026Market cap $195.97MP/E –Yield –

Precision BioSciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Precision BioSciences's price to book ratio was 5.3× on Nov 11, 2026, against 4.0× a year earlier. Over the last 5 years it ranged from 0.4× to 5.3×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.3×+2.3
2025Dec 31, 20253.0×+2.6
2024Dec 31, 20240.4×−1.0
2023Dec 29, 20231.5×−0.1
2022Dec 30, 20221.6×−2.8
2021Dec 31, 20214.4×−2.5
2020Dec 31, 20206.9×+2.3
2019Dec 31, 20194.5×–

More Precision BioSciences figures

See a number that looks wrong?